• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Lymph node ratio as a predictive factor for combined surgical resection in patients with synchronous

Lymph node ratio as a predictive factor for combined surgical resection in patients with synchronous

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：nlqysb
【摘 要】
：
Objective: The purpose of this study was to evaluate the prognostic value of lymph node ratio (LNR) in gastric cancer liver metastases patients who received combined surgical resection.
【作 者】
：
Mu-xing Li Hong Zhao Xin-yu Bi Zhen Huang Zhi-yu Li Yue Han Jian-guo Zhou Ye-fan Zhang Jian-jun Zhao Jian-qiang Cai 
【机 构】
：
Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences
【出 处】
：
第十八届全国临床肿瘤学大会暨2015年CSCO学术年会
【发表日期】
：
2015年4期
【关键词】
：
lymph node ratio gastric cancer liver metastases 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Objective: The purpose of this study was to evaluate the prognostic value of lymph node ratio (LNR) in gastric cancer liver metastases patients who received combined surgical resection.
其他文献
乳腺癌术后上肢淋巴水肿的治疗与预防现状及进展
目的：乳腺癌是在我国女性中发病率居首的恶性肿瘤,且发病率正以3％的速度逐年上升,2014年已达25.89％.目前,逐渐规范的手术及辅助治疗使得乳腺癌的治愈率逐渐升高,但上肢淋巴水肿作为术后主要的并发症之一,对医生而言是一项具有挑战的问题.
会议
乳腺癌术后淋巴水肿淋巴水肿预防即刻淋巴静脉吻合
Implication of combined PD-L1/PD-1 blockade with Cytokine-induced killer cells as a synergistic immu
Objective: Cytokine-induced killer (CIK) cells represent a realistic approach in cancer immunotherapy with confirmed survival benefits in the context of metastatic solid tumors that are unmanageable u
会议
PD-L1/PD-1CIKNKG2D
Clinical Prognostic Scoring System for resectable gastric cancer predicts survival and benefit from
Objective: D2 gastrectomy is a standard procedure of curative resection for gastric cancer.This study aims to develop a simple and reliable prognostic scoring system for gastric cancer with D2 gastrec
会议
gastric cancerprognosisscore system
Pathe era of oxaliplatin-based adjuvant hological stage N2 rectal cancer patients might benefit from
Objective: To evaluate radiochemotherapeutic sequence for pathological stage N2 rectal cancer in the era of oxaliplatin-based adjuvant therapy.Method: Treatment outcomes and impact of different sequen
会议
Adjuvant chemoradiotherapySequenceRectal cancer
18F-FDG-PET/CT对复发转移乳腺癌缓解率早期预测的临床研究
目的：本文旨在对18F-FDG-PET/CT早期预测复发转移乳腺癌缓解率的价值进行研究。方法：选择2007年～2014年复发转移的乳腺癌患者18例，所有患者均于治疗前和化疗一周期后均行PET/CT检查1次，统计分析客观缓解(OR)组与未达客观缓解(non-OR)组患者之间PET/CT1、PET/CT2、SUV、SUV变化率比较，代谢反应组与代谢无反应组患者OR、DCR的比较。
会议
PET/CT复发转移乳腺癌缓解
A multicenter, randomized, controlled clinical trial to explore the effect of 5-Fluorouracil combine
Objective: The prognosis for unresectable metastatic colorectal cancers is poor, and improved therapies are needed.Recent studies have shown the activated NLRP3 inflammasome was one of the machanism t
会议
colorectal cancerFluorouracilandrographolide
Broad, hybrid capture-based next generation sequencing in metastatic colorectal cancer facilitated p
Objective: Patients with metastatic colorectal cancer are now recommended to profile for RAS and BRAF mutations before receiving cetuximab or panitumumab.However, lots of patients with both RAS and BR
会议
colorectal cancergenetic alterationnext generation
Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the
Objective: To investigate the safety, clinical efficacy, and long-term outcome of TACE plus As2O3 intravenous infusion for HCC patients with pulmonary metastases.
会议
TACEAs2O3HCC with pulmonary metastasis
Synchronous resectable metastatic colorectal cancer:lymph node involvement predicts poor outcome
Objective: To evaluate the value of lymph node status of primary tumors in predicting the prognosis of synchronous resectable metastatic colorectal cancer (mCRC).
会议
resectable metastatic colorectal cancer (mCRC)SEE
Impact of preoperative body mass index and body mass index variation on disease-free survival after
Objective: To investigate the relations of preoperative body mass index (BMI) with the change in BMI during perioperative period and disease-free survival (DFS) in patients with gastric cancer.
会议
Gastric cancerBMIDFS